AU672149B2 - Method of increasing vaginal lubrication - Google Patents
Method of increasing vaginal lubrication Download PDFInfo
- Publication number
- AU672149B2 AU672149B2 AU81599/94A AU8159994A AU672149B2 AU 672149 B2 AU672149 B2 AU 672149B2 AU 81599/94 A AU81599/94 A AU 81599/94A AU 8159994 A AU8159994 A AU 8159994A AU 672149 B2 AU672149 B2 AU 672149B2
- Authority
- AU
- Australia
- Prior art keywords
- hydriodic acid
- vaginal
- increased
- sexual desire
- hydriodic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
1
AUSTRALIA
PATENTS ACT 1990 CO m P T TP S P E r T f T r Z M T rW u~uusLi~~ssv~ FOR A STANDARD PATENT
ORIGINAL
r Name of Applicant: Actual Inventor: Address for Service: SUSANN R. REILLY Susann R. REILLY SHELSTON WATERS Clarence Street SYDNEY NSW 2000 "METHOD OF INCREASING VAGINAL LUBRICATION" o *p oo Invention Title: Details of Original Application No. 40248/93 dated 31st March 1993 The following statement is a full description of this invention, including the best method of performing it known to me:-
I
la- Description Background of the Invention From the dawn of recorded history many substances have been used for the purpose of sexual enhancement. Some of these have known success and their reputations have been passed down through the millennia. Even though none of these substances have survived the rigors of scientific scrutiny the pursuit for an aphrodisiac continues. As long as humans place value on optimal sexual functioning, there will be a demand for sex-enhancing drugs.
Summary of the Invention This invention relates to the use of hydriodic acid in an aqueous solution as an aphrodisiac to heighten sexual desire.
According to a broad format the invention consists in a method of effecting one or more of heightened sexual desire, increased vaginal secretion, increased vaginal 5 lubrication, clitoral swelling, nipple erection and contraction of vaginal musculature in 15 an adult human female, comprising administering to the female an effective amount of an aqueous solution of hydriodic acid.
Preferably the hydriodic acid solution is in the form of a syrup comprising hydriodic acid, water and dextrose, which can be optionally diluted further before administration.
S 20 Detailed Description of the Invention This invention is based upon the discovery that an aqueous solution of hydriodic acid (hydriodic solution) can heighten sexual desire and, as such, can be used as an aphrodisiac.
Hydriodic acid is also known as anhydrous hydriodic acid, hydrogen iodide, hydrogen monoiodide or hydriodic. At normal temperature, hydriodic acid is a colourless and nonflammable gas. See The Merck Index, Merck Co., Inc. (Tenth Edition 1983).
The hydriodic acid solution of the present invention consists of hydriodic acid in purified water and dextrose.
It has now been discovered that an aqueous solution of hydriodic acid has aphrodisiac activity as confirmed through its use by a female human. After the oral administration of the hydriodic acid solution, an aphrodisiac effect was experienced by said female.
The term "aphrodisiac" or "heightened sexual desire", for purposes of the present invention, refers to the following physical manifestations of ingesting the hydriodic solution: increased vaginal secretion, clitoral swelling, nipple erection, contraction of vaginal musculature and a general tingling sensation.
Increased vaginal secretion resulted in an increase in the amount of transudate present in the vagina, resulting in increased vaginal lubrication.
The invention will be further illustrated by the following non-limiting Exemplification:
EXEMPLIFICATION
Hydriodic acid solution was purchased from Eli Lilly and Company, of Indianapolis, Indiana, referred to as hydriodic acid syrup. The hydriodic acid syrup is prepared by mixing 140 mL of hydriodic acid with 550 mL of purified water and dissolving 450 g of dextrose into the mixture.
The solution was orally administered to a female human 52 years age, weighing 75 kg. About 2.5 to 15 mL teaspoons of the hydriodic syrup was placed into 240 mL of tap water and then ingested. An aphrodisiac effect, as defined above, was experienced within approximately 24 hours.
It is understood that higher or lower amounts and concentrations of the hydriodic solution would be used for heavier or lighter subjects as the purview of one skilled in the 20 o ee r go oe -3- It should be, as well, understood that other types of administration of the hydriodic solution may be used, such as topical administration.
Esmivalento Those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the 10 following claims:
Claims (13)
1. A method of effecting one or more of heightened sexual desire, increased vaginal secretion, increased vaginal lubricatioi, clitoral swelling, nipple erection and contraction of vaginal musculature in an adult human female, comprising administering to the female an effective amount of an aqueous solution of hydriodic acid.
2. A method according to Claim 1, wherein said method effects heightened sexual desire.
3. A method according to Claim 1, wherein said method effects increased vaginal secretion.
4. A method according to Claim 1, wherein said method effects increased vaginal lubrication.
A method according to Claim 1, wherein said method effects increased clitoral swelling.
6. A method according to Claim 1, wherein said method effects increased nipple erection.
7. A method according to Claim 1, wherein said method effects increased contraction of vaginal musculature.
8. A method according to any one of Claims I to 7, wherein the hydriodic acid solution comprises hydriodic acid, water and dextrose.
9. A method according to any one of Claims 1 to 8, wherein the hydriodic acid solution is in the form of a syrup comprising 140 mL of hydriodic acid, 550 mL of purified water and 450 of dextrose.
10. A method according to any one of Claims 1 to 9, wherein the effective amount of hydriodic acid is approximately 2.5 to 15 mL of hydriodic acid syrup.
11. A method according to Claim 10, wherein the effective amount of hydriodic acid syrup is added to approximately 240 mL of water before administration.
12. A method according to any one of Claims 1 to 11, wherein administration is oral administration.
13. A method of effecting one or more of heightened sexual desire, increased vaginal secretion, increased vaginal lubrication, clitoral swelling, nipple erection and contraction of vaginal musculature, substantially as hereinbefore described with reference to the Example. DATED this 17th day of May, 1996. SUSANN R. REILLY Attorney: IAN T. ERNST Fellow Institute of Patent Attorneys of Australia of S HELSTON WATERS 6 x 7 1 vi Ik^AA- j
17733-00 DOC/iar ABSTRACT This invention relates to the use of hydriodic acid in an aqueous solution as an aphrodisiac to heighten sexual desire.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US862454 | 1992-04-02 | ||
| US07/862,454 US5281423A (en) | 1992-04-02 | 1992-04-02 | Use of hydriodic acid as an aphrodisiac |
| US08/170,151 US5470588A (en) | 1992-04-02 | 1993-12-20 | Method of increasing vaginal lubrication |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU40248/93A Division AU666196B2 (en) | 1992-04-02 | 1993-03-31 | Use of hydriodic acid as an aphrodisiac |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8159994A AU8159994A (en) | 1995-02-16 |
| AU672149B2 true AU672149B2 (en) | 1996-09-19 |
Family
ID=26865763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU81599/94A Expired AU672149B2 (en) | 1992-04-02 | 1994-12-19 | Method of increasing vaginal lubrication |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | USRE36320E (en) |
| AU (1) | AU672149B2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5783254A (en) * | 1980-11-12 | 1982-05-25 | Nippon Nousan Kogyo Kk | Feed for animal |
| US4670256A (en) * | 1985-09-23 | 1987-06-02 | V. Valhalla Corp. | Vaginal conditioning for sexual activity |
-
1994
- 1994-12-19 AU AU81599/94A patent/AU672149B2/en not_active Expired
-
1997
- 1997-11-26 US US08/979,152 patent/USRE36320E/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU8159994A (en) | 1995-02-16 |
| USRE36320E (en) | 1999-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wallach et al. | Metabolic and renal effects of acute hypercalcemia in dogs | |
| Beghè et al. | Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients | |
| AU672149B2 (en) | Method of increasing vaginal lubrication | |
| EP0633723B1 (en) | Use of hydriodic acid as an aphrodisiac | |
| Le et al. | Ibuprofen overdose complicated by renal failure, adult respiratory distress syndrome, and metabolic acidosis | |
| Schulert et al. | The physiologic disposition of phenylindanedione in man | |
| Wyngaarden | The effect of phenylbutazone on uric acid metabolism in two normal subjects | |
| Bavbek et al. | Recurrent hyponatremia associated with citalopram and mirtazapine | |
| Danesh et al. | Is an acid pH medium required for the protective effect of sucralfate against mucosal injury? | |
| Galinsky et al. | Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate | |
| Siafakas et al. | Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson’s disease | |
| RU2012350C1 (en) | Agent for removing alcohol intoxication | |
| US20030108621A1 (en) | Use of iodide salt as an aphrodisiac | |
| Martin et al. | The interaction of paracetamol with frusemide. | |
| JPH05262660A (en) | Tricomponent formulation | |
| Suarez et al. | Intentional Overdosage with Propanolol: A Report of Two Cases | |
| Eradiri et al. | Steady‐state pharmacokinetics of metronidazole in Crohn's disease | |
| Mathew | Prophylactic pharmacotherapy of cluster headache | |
| Formulary | Essential Drugs | |
| PH26636A (en) | Method and composition to treat panic syndrome | |
| Saunders et al. | A comprehensive computer simulation of drug metabolism and pharmacokinetics | |
| Superior et al. | Alasil | |
| US20080146592A1 (en) | Method of Treating Preeclampsia Employing Metolazone | |
| Hall et al. | Psychiatric and physiological reactions produced by over-the-counter medications | |
| Septra | THE B. 1. 11~ DOSAGE~ ADWXNTAGE. |